glp-1 future prospects
7 Prescription Weight Loss Showdowns: Drugs vs Surgery
GLP-1 receptor agonists are rapidly reshaping the prescription weight-loss market by delivering clinically meaningful weight loss, driving multi-billion-dollar sales, and prompting new investment streams. Their dual effect on appetite and glucose control has turned them into a cornerstone of modern obesity therapy. In 2023, U.S. pharmacies shipped 12 million